Accumulus Synergy
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.accumulus.orgRevenue
<$5 MillionIndustry
About Accumulus Synergy
Funded by ten leading biopharma companies, the non-profit Accumulus Synergy, Inc. was formed in 2020 to create a cloud-based platform, to transform data sharing between the biopharma industry and global health authorities. The common-platform approach aims to improve efficiencies in the regulatory process by leveraging advanced technology, including data science and AI, as well as tools for secure data exchange to improve patient safety, help reduce the cost of innovation, and ultimately bring patients safe and effective medicines faster. It will work with partner companies, key stakeholders, and global health authorities to build and sustain a platform that meets regulatory, cybersecurity, and privacy requirements spanning clinical, safety, chemistry and manufacturing, and regulatory exchanges and submissions.Explore more
Accumulus Synergy Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Accumulus Synergy
Compare insights from companies similar to Accumulus Synergy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Accumulus Synergy Tech Stack
A closer look at the technologies used by Accumulus Synergy
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Accumulus Synergy
Sign Up For FreeTo access detailed company insights
Funded by ten leading biopharma companies, the non-profit Accumulus Synergy, Inc. was formed in 2020 to create a cloud-based platform, to transform data sharing between the biopharma industry and global health authorities. The common-platform approach aims to improve efficiencies in the regulatory process by leveraging advanced technology, includin... Read More
